03/04/2021
4:12 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2021
4:05 PM | Arbutus Biopharma (Filer)
| Form 424B5
| |
03/04/2021
3:32 PM | Arbutus Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2021
6:32 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2021
6:32 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/17/2021
4:06 PM | Arbutus Biopharma (Issuer)
HASTINGS DAVID C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
3:57 PM | Arbutus Biopharma (Issuer)
Howard Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
3:55 PM | Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
3:52 PM | Arbutus Biopharma (Issuer)
Sofia Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
9:46 AM | Arbutus Biopharma (Subject)
Foresite Capital Fund IV, L.P. (Filed by)
| Form SC 13G/A
| |
|
02/12/2021
8:23 AM | Arbutus Biopharma (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A
| |
02/10/2021
4:06 PM | Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2021
11:13 AM | Arbutus Biopharma (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A
| |
02/01/2021
6:30 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2021
6:32 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2020
3:33 PM | Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2020
6:32 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2020
7:00 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2020
3:11 PM | Arbutus Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020
7:30 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2020
11:15 PM | Arbutus Biopharma (Filer)
| Form EFFECT
| |
09/25/2020
3:06 PM | Arbutus Biopharma (Issuer)
Picchio Gaston (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2020
3:05 PM | Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2020
6:32 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2020
3:39 PM | Arbutus Biopharma (Filer)
| Form CT ORDER
| |
08/28/2020
3:06 PM | Arbutus Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/27/2020
7:17 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2020
5:44 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2020
4:24 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2020
3:54 PM | Arbutus Biopharma (Filer)
| Form 424B5
| |
08/07/2020
3:48 PM | Arbutus Biopharma (Filer)
| Form 424B5
| |
08/07/2020
6:34 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/27/2020
4:27 PM | Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2020
8:13 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2020
11:56 AM | Arbutus Biopharma (Filer)
| Form CT ORDER
| |
07/16/2020
3:22 PM | Arbutus Biopharma (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G
| |
06/24/2020
3:22 PM | Arbutus Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/01/2020
4:04 PM | Arbutus Biopharma (Issuer)
Meyers James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:03 PM | Arbutus Biopharma (Issuer)
HENRIQUES RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:02 PM | Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:01 PM | Arbutus Biopharma (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2020
7:29 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2020
7:02 AM | Arbutus Biopharma (Filer)
| Form DEF 14A
| |
03/26/2020
4:17 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2020
3:06 PM | Arbutus Biopharma (Filer)
| Form 10-K/A
| |
03/05/2020
6:33 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
7:05 AM | Arbutus Biopharma (Issuer)
Howard Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
7:05 AM | Arbutus Biopharma (Issuer)
Sofia Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
7:04 AM | Arbutus Biopharma (Issuer)
Picchio Gaston (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
7:04 AM | Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
7:03 AM | Arbutus Biopharma (Issuer)
HASTINGS DAVID C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
7:02 AM | Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
7:01 AM | Arbutus Biopharma (Issuer)
Venker Eric (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/19/2020
7:00 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
12:50 PM | Arbutus Biopharma (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A
| |
02/14/2020
12:44 PM | Arbutus Biopharma (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A
| |
02/10/2020
7:05 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
7:45 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2019
3:09 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2019
7:24 PM | Arbutus Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/09/2019
1:15 PM | Arbutus Biopharma (Subject)
Foresite Capital Fund IV, L.P. (Filed by)
| Form SC 13G
| |
11/06/2019
11:27 AM | Arbutus Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
6:34 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2019
1:42 PM | Arbutus Biopharma (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SC 13G
| |
10/03/2019
3:16 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2019
3:14 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2019
3:18 PM | Arbutus Biopharma (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
3:17 PM | Arbutus Biopharma (Issuer)
POTTER MYRTLE S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
3:17 PM | Arbutus Biopharma (Issuer)
Cheng Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/20/2019
3:17 PM | Arbutus Biopharma (Issuer)
BURGESS DANIEL D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
3:16 PM | Arbutus Biopharma (Issuer)
Meyers James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
3:16 PM | Arbutus Biopharma (Issuer)
MANCHESTER KEITH S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
3:15 PM | Arbutus Biopharma (Issuer)
HENRIQUES RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
3:15 PM | Arbutus Biopharma (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
3:09 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2019
3:31 PM | Arbutus Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/09/2019
3:05 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2019
11:29 AM | Arbutus Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2019
10:32 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2019
3:05 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2019
4:30 PM | Arbutus Biopharma (Subject)
Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A
| |
07/15/2019
8:35 PM | Arbutus Biopharma (Issuer)
Lo Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2019
8:33 PM | Arbutus Biopharma (Issuer)
Machado Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2019
7:40 PM | Arbutus Biopharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VGE III Portfolio Ltd. (Reporting)
Viking Global Equities II LP (Reporting)
Viking Global Equities LP (Reporting)
Viking Global Equities Master Ltd. (Reporting)
VIKING GLOBAL PERFORMANCE LLC (Reporting)
Viking Long Fund GP LLC (Reporting)
Viking Long Fund Master Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2019
7:38 PM | Arbutus Biopharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2019
6:46 PM | Arbutus Biopharma (Issuer)
SoftBank Vision Fund L.P. (Reporting)
SVF Investments Ltd (0001716729) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2019
3:57 PM | Arbutus Biopharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A
| |
07/12/2019
3:51 PM | Arbutus Biopharma (Issuer)
Dexcel Pharma Technologies Ltd. (Reporting)
Dexxon Holdings Ltd. (Reporting)
Oren Dan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2019
3:47 PM | Arbutus Biopharma (Subject)
QVT Financial LP (Filed by)
| Form SC 13D/A
| |
07/12/2019
3:45 PM | Arbutus Biopharma (Subject)
Dexxon Holdings Ltd. (Filed by)
| Form SC 13D/A
| |
07/12/2019
3:39 PM | Arbutus Biopharma (Issuer)
QVT Associates GP LLC (Reporting)
QVT Fund V LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2019
3:34 PM | Arbutus Biopharma (Subject)
SVF Investments Ltd (0001716729) (Filed by)
| Form SC 13D/A
| |
07/03/2019
3:28 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2019
3:18 PM | Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
3:18 PM | Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/18/2019
3:00 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2019
3:53 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2019
5:07 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2019
4:30 PM | Arbutus Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2019
4:02 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
